• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常孕期中活化蛋白C抵抗的变化

Changes in activated protein C resistance during normal pregnancy.

作者信息

Walker M C, Garner P R, Keely E J, Rock G A, Reis M D

机构信息

Department of Obstetrics and Gynecology, University of Ottawa, Ontario, Canada.

出版信息

Am J Obstet Gynecol. 1997 Jul;177(1):162-9. doi: 10.1016/s0002-9378(97)70456-3.

DOI:10.1016/s0002-9378(97)70456-3
PMID:9240601
Abstract

OBJECTIVE

The objective of this study was to determine the changes in activated protein C resistance that occur during normal pregnancy.

STUDY DESIGN

In this cross-sectional study activated protein C was measured in 128 women with normal pregnancies in the first, second, and third trimesters and in nonpregnant control subjects with 24 to 39 women in each group. In addition, factor V, factor VIII, free protein S, and functional protein C were measured and correlated with activated protein C levels. Polymerase chain reaction for factor V Leiden mutation was performed.

RESULTS

There was a significant fall in the activity of activated protein C in the second and third trimesters of pregnancy (p < 0.05). This was related to increased factor VIII and decreased free protein S levels (p = 0.002, R2 = 0.20). The prevalence of the factor V Leiden mutation was 7.3%.

CONCLUSION

Resistance to activated protein C is increased in the second and third trimesters of pregnancy. This is related to the alterations in other coagulation proteins, a phenomenon normally occurring during pregnancy.

摘要

目的

本研究的目的是确定正常妊娠期间活化蛋白C抵抗的变化情况。

研究设计

在这项横断面研究中,对128例妊娠各期(孕早期、孕中期和孕晚期)的正常孕妇以及非孕对照者(每组24至39名女性)进行活化蛋白C检测。此外,还检测了凝血因子V、凝血因子VIII、游离蛋白S和功能性蛋白C,并分析它们与活化蛋白C水平的相关性。进行了凝血因子V莱顿突变的聚合酶链反应检测。

结果

妊娠中期和晚期活化蛋白C活性显著下降(p < 0.05)。这与凝血因子VIII增加和游离蛋白S水平降低有关(p = 0.002,R2 = 0.20)。凝血因子V莱顿突变的发生率为7.3%。

结论

妊娠中期和晚期对活化蛋白C的抵抗增加。这与其他凝血蛋白的变化有关,是妊娠期间正常出现的一种现象。

相似文献

1
Changes in activated protein C resistance during normal pregnancy.正常孕期中活化蛋白C抵抗的变化
Am J Obstet Gynecol. 1997 Jul;177(1):162-9. doi: 10.1016/s0002-9378(97)70456-3.
2
Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
Gynecol Obstet Invest. 2007;64(2):89-94. doi: 10.1159/000100009. Epub 2007 Feb 20.
3
Haemostatic changes and acquired activated protein C resistance in normal pregnancy.正常妊娠中的止血变化与获得性活化蛋白C抵抗
Blood Coagul Fibrinolysis. 2007 Oct;18(7):685-8. doi: 10.1097/MBC.0b013e3282f09835.
4
Changes in the plasma activities of protein C and protein S during pregnancy.孕期蛋白C和蛋白S的血浆活性变化。
Aust N Z J Obstet Gynaecol. 2000 Nov;40(4):448-50. doi: 10.1111/j.1479-828x.2000.tb01179.x.
5
Changes in protein C and protein S levels in normal pregnancy.
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):147-50. doi: 10.1016/0002-9378(95)90104-3.
6
Activated-protein-C resistance in cancer patients.癌症患者的活化蛋白C抵抗
Haemostasis. 1997 May-Jun;27(3):112-8. doi: 10.1159/000217442.
7
First-trimester repeated abortion is not associated with activated protein C resistance.孕早期反复流产与活化蛋白C抵抗无关。
Hum Reprod. 1997 May;12(5):1094-7. doi: 10.1093/humrep/12.5.1094.
8
Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy.正常妊娠时活化蛋白C敏感性、蛋白C、蛋白S与凝血情况
Thromb Haemost. 1998 Jun;79(6):1166-70.
9
Activated protein C resistance in normal and pre-eclamptic pregnancies.正常妊娠和子痫前期妊娠中的活化蛋白C抵抗
Gynecol Obstet Invest. 2002;54(3):145-9. doi: 10.1159/000067878.
10
Longitudinal evaluation of activated protein C resistance among normal pregnancies of Hispanic women.西班牙裔女性正常妊娠期间活化蛋白C抵抗的纵向评估
Am J Obstet Gynecol. 2000 Jun;182(6):1433-6. doi: 10.1067/mob.2000.106134.

引用本文的文献

1
Challenges in Cerebral Venous Thrombosis Management-Case Reports and Short Literature Review.脑静脉血栓形成管理中的挑战——病例报告与简短文献综述
Life (Basel). 2023 Jan 26;13(2):334. doi: 10.3390/life13020334.
2
Perturbations in kinetics of the thrombin generation assay identify women at risk of preeclampsia in the first trimester and provide the rationale for a preventive approach.在第一孕期中,凝血酶生成分析动力学的改变可以识别出患有先兆子痫的高风险女性,为预防性治疗提供了理论依据。
Am J Obstet Gynecol. 2023 May;228(5):580.e1-580.e17. doi: 10.1016/j.ajog.2022.11.1276. Epub 2022 Nov 8.
3
DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.
妊娠期弥散性血管内凝血——病理生理学、临床特征、诊断评分及治疗
J Blood Med. 2022 Jan 6;13:21-44. doi: 10.2147/JBM.S273047. eCollection 2022.
4
Uterine Radial Artery Resistance Index Predicts Reproductive Outcome in Women with Recurrent Pregnancy Losses and Thrombophilia.子宫放射状动脉阻力指数预测复发性妊娠丢失伴血栓形成倾向妇女的生殖结局。
Biomed Res Int. 2019 Jun 20;2019:8787010. doi: 10.1155/2019/8787010. eCollection 2019.
5
The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.子痫前期女性与无子痫前期的小于胎龄儿女性的“体内凝血酶生成”模式和程度有所不同。
J Matern Fetal Neonatal Med. 2018 Jul;31(13):1671-1680. doi: 10.1080/14767058.2017.1323327. Epub 2017 May 23.
6
Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.胎盘血管病理学和凝血酶生成增加作为产科综合征疾病的机制。
PeerJ. 2014 Nov 18;2:e653. doi: 10.7717/peerj.653. eCollection 2014.
7
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pregnancy in pulmonary hypertension.沙特肺高血压诊断和治疗指南:肺高血压与妊娠。
Ann Thorac Med. 2014 Jul;9(Suppl 1):S108-12. doi: 10.4103/1817-1737.134050.
8
Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.获得性活化蛋白C抵抗、血栓形成倾向与不良妊娠结局:在爱尔兰孕妇队列中开展的一项研究
J Pregnancy. 2011;2011:232840. doi: 10.1155/2011/232840. Epub 2011 Aug 14.
9
Natural coagulation inhibitors and active protein c resistance in preeclampsia.子痫前期中的天然凝血抑制剂和活性蛋白 C 抵抗。
Clinics (Sao Paulo). 2010;65(11):1119-22. doi: 10.1590/s1807-59322010001100011.
10
APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.爱尔兰孕妇队列中 APCR、已知和新型因子 V 基因突变与不良妊娠结局的关系。
BMC Pregnancy Childbirth. 2010 Mar 10;10:11. doi: 10.1186/1471-2393-10-11.